Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants

Viruses are a major cause of mortality and socio-economic downfall despite the plethora of biopharmaceuticals designed for their eradication. Conventional antiviral therapies are often ineffective. Live-attenuated vaccines can pose a safety risk due to the possibility of pathogen reversion, whereas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharifi, Esmaeel, Yousefiasl, Satar, Trovato, Maria, Sartorius, Rossella, Esmaeili, Yasaman, Goodarzi, Hamid, Ghomi, Matineh, Bigham, Ashkan, Moghaddam, Farnaz Dabbagh, Heidarifard, Maryam, Pourmotabed, Samiramis, Nazarzadeh Zare, Ehsan, Paiva-Santos, Ana Cláudia, Rabiee, Navid, Wang, Xiangdong, Tay, Franklin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283343/
https://www.ncbi.nlm.nih.gov/pubmed/37344894
http://dx.doi.org/10.1186/s12951-023-01938-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283343/
https://www.ncbi.nlm.nih.gov/pubmed/37344894
http://dx.doi.org/10.1186/s12951-023-01938-8

Ejemplares similares